Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 07:00 ET | Source: Alesta Therapeutics

Alesta to Highlight ALE1 Clinical Progress at 44th Annual JP Morgan Healthcare Conference

Lead program ALE1 for hypophosphatasia (HPP) progressing through the clinic with a Ph1/2a study currently ongoing in healthy volunteers; HPP patients expected to be dosed in H1 2026 Second...